Carbon Liberated from CO-releasing Molecules Attenuates Leukocyte Infiltration in the Small Intestine of Thermally Injured Mice
Overview
Affiliations
Aim: To determine whether Carbon (CO) liberated from CO-releasing molecules attenuates leukocyte infiltration in the small intestine of thermally injured mice.
Methods: Thirty-six mice were assigned to four groups. Mice in the sham group (n = 9) were underwent to sham thermal injury; mice in the burn group (n = 9) received 15% total body surface area full-thickness thermal injury; mice in the burn + CORM-2 group (n = 9) were underwent to the same thermal injury with immediate administration of tricarbonyldichlororuthenium (II) dimer CORM-2 (8 mg/kg, i.v.); and mice in the burn+DMSO group (n = 9) were underwent to the same thermal injury with immediate administration of 160 muL bolus injection of 0.5% DMSO/saline. Histological alterations and granulocyte infiltration of the small intestine were assessed. Polymorphonuclear neutrophil (PMN) accumulation (myeloperoxidase assay) was assessed in mice mid-ileum. Activation of nuclear factor (NF)-kappa B, expression levels of intercellular adhesion molecule-1 (ICAM-1) and inducible heme oxygenase in mid-ileum were assessed.
Results: Treatment of thermally injured mice with CORM-2 attenuated PMN accumulation and prevented activation of NF-kappa B in the small intestine. This was accompanied by a decrease in the expression of ICAM-1. In parallel, burn-induced granulocyte infiltration in mid-ileum was markedly decreased in the burn mice treated with CORM-2.
Conclusion: CORM-released CO attenuates leukocyte infiltration in the small intestine of thermally injured mice by interfering with NF-kappa B activation and protein expression of ICAM-1, and therefore suppressing the pro-adhesive phenotype of endothelial cells.
Carbon monoxide releasing molecule‑2 (CORM‑2)‑liberated CO ameliorates acute pancreatitis.
Liu Y, Wang X, Xu X, Qin W, Sun B Mol Med Rep. 2019; 19(6):5142-5152.
PMID: 31059081 PMC: 6522929. DOI: 10.3892/mmr.2019.10173.
Protective effects of carbon monoxide releasing molecule‑2 on pancreatic function in septic mice.
Liu Y, Wang X, Xu X, Qin W, Sun B Mol Med Rep. 2019; 19(5):3449-3458.
PMID: 30896839 PMC: 6470989. DOI: 10.3892/mmr.2019.10049.
Shen W, Wang X, Qin W, Qiu X, Sun B Acta Pharmacol Sin. 2014; 35(12):1566-76.
PMID: 25399652 PMC: 4261131. DOI: 10.1038/aps.2014.99.
CO and CO-releasing molecules (CO-RMs) in acute gastrointestinal inflammation.
Babu D, Motterlini R, Lefebvre R Br J Pharmacol. 2014; 172(6):1557-73.
PMID: 24641722 PMC: 4369264. DOI: 10.1111/bph.12632.
Emerging concepts on the anti-inflammatory actions of carbon monoxide-releasing molecules (CO-RMs).
Motterlini R, Haas B, Foresti R Med Gas Res. 2012; 2(1):28.
PMID: 23171578 PMC: 3536644. DOI: 10.1186/2045-9912-2-28.